Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Extremely low viral reservoir in treated chronically HIV-1-infected individuals.
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study.
A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV.
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
HIV-1 envelope glycoproteins isolated from Viremic Non-Progressor individuals are fully functional and cytopathic.
Production of HIV-1-based virus-like particles for vaccination: achievements and limits.
CD4 recovery is associated with genetic variation in IFNγ and IL19 genes.
Combined assessment of peritumoral Th1/Th2 polarization and peripheral immunity as a new biomarker in the prediction of BCG response in patients with high-risk NMIBC.
IL7RA rs6897932 Polymorphism is Associated with Better CD4 + T-Cell Recovery in HIV Infected Patients Starting Combination Antiretroviral Therapy.
Evolution of the gut microbiome following acute HIV-1 infection.